1.
|
Phase: Phase III Type: Treatment Status: Active Age: 54 and under Sponsor: Other Protocol IDs: 0107M05202, MT2001-02, NCT00176930
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000581078, U01CA121947, AMC-053, NCT00598169
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: FDA IND 100712, NCT00611208
|
|
4.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 0711003269, NCT00785798
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 060051, 06-C-0051, NCT00267865
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: Under 70 Sponsor: Other Protocol IDs: 2005LS048, UMN-0508M72589, UMN-MT2004-24, UMN-2005LS048, NCT00345865
|
|
7.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 75 and under Sponsor: NCI, Other Protocol IDs: 2212.00, NCI-2009-01244, P01CA018029, U19AI096111, NCT00968630
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 0 to 26 Sponsor: Other Protocol IDs: L 10,321, NYMC 525, NCT01049854
|
|
9.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2010-0284, NCT01200485
|
|
10.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 21 and under Sponsor: Other Protocol IDs: UCBT01, NCT01328496
|
|
11.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Active Age: any age Sponsor: Other Protocol IDs: 11-130, NCT01498484
|
|
12.
|
Phase: Phase I Type: Treatment Status: Active Age: Under 65 Sponsor: NCI, Other Protocol IDs: 1410.00, NCI-2010-00802, P01CA018029, FHCRC-1410.00, NCT00112593
|
|
13.
|
Phase: Phase I Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2009-0521, NCT01015222
|
|
14.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 3129K2-1105, B1931003, NCT01055496
|
|
15.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: Debio 1143-101 (AT-406-CS-001), NCT01078649
|
|
16.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: TED10893, U1111-1116-5472, NCT01084252
|
|
17.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 101-99, NCT01090414
|
|
18.
|
Phase: Phase I Type: Treatment Status: Active Age: any age Sponsor: Other Protocol IDs: 2009-0855, NCT01113476
|
|
19.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2010-0108, NCT01183663
|
|
20.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2010-0588, NCT01266057
|
|
21.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 110060, 11-C-0060, NCT01273155
|
|
22.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: DCS4968g, GO01294, NCT01290549
|
|
23.
|
Phase: Phase I Type: Treatment Status: Active Age: Any age Sponsor: NCI, Other Protocol IDs: H-27471-TACTAL, TACTAL, NCT01333046
|
|
24.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-041, NCT01393509
|
|
25.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: GP27839, NCT01546519
|